OBJECTIVES: Self-monitoring is recommended for individuals with bipolar disorder, with numerous technological solutions available. This study aimed to identify basic components of these solutions that increase engagement with self-monitoring. METHODS:Participants with bipolar disorder (n = 47) monitored their symptoms with a Fitbit and a smartphone app and were randomly assigned to either review or not review recorded symptoms weekly. We tested whether individuals would better adhere to and prefer monitoring with passive monitoring with an activity tracker compared to active monitoring with a smartphone app and whether individuals would better adhere to self-monitoring if their recorded symptoms were reviewed with an interviewer. RESULTS: Monitoring with a smartphone app achieved similar adherence and preference to Fitbit (P > .85). Linear mixed effects modeling found adherence decreased significantly more over the study for the Fitbit (12% more, P < .001) even though more participants reported they would use the Fitbit over a year compared to the app (72.3% vs 46.8%). Reviewing symptoms weekly did not improve adherence, but most participants reported they would prefer to review symptoms with a clinician (74.5%) and on monthly basis (57.5%) compared to alternatives. Participants endorsed sleep as the most important symptom to monitor, forgetfulness as the largest barrier to self-monitoring, and raising self-awareness as the best reason for self-monitoring. CONCLUSIONS: We recommend a combined strategy of wearable and mobile monitoring that includes reminders, targets raising self-awareness, and tracks sleep. A clinician may want to review symptoms on a monthly basis. TRIAL REGISTRATION: ClinicalTrials.gov NCT03358238.
RCT Entities:
OBJECTIVES: Self-monitoring is recommended for individuals with bipolar disorder, with numerous technological solutions available. This study aimed to identify basic components of these solutions that increase engagement with self-monitoring. METHODS:Participants with bipolar disorder (n = 47) monitored their symptoms with a Fitbit and a smartphone app and were randomly assigned to either review or not review recorded symptoms weekly. We tested whether individuals would better adhere to and prefer monitoring with passive monitoring with an activity tracker compared to active monitoring with a smartphone app and whether individuals would better adhere to self-monitoring if their recorded symptoms were reviewed with an interviewer. RESULTS: Monitoring with a smartphone app achieved similar adherence and preference to Fitbit (P > .85). Linear mixed effects modeling found adherence decreased significantly more over the study for the Fitbit (12% more, P < .001) even though more participants reported they would use the Fitbit over a year compared to the app (72.3% vs 46.8%). Reviewing symptoms weekly did not improve adherence, but most participants reported they would prefer to review symptoms with a clinician (74.5%) and on monthly basis (57.5%) compared to alternatives. Participants endorsed sleep as the most important symptom to monitor, forgetfulness as the largest barrier to self-monitoring, and raising self-awareness as the best reason for self-monitoring. CONCLUSIONS: We recommend a combined strategy of wearable and mobile monitoring that includes reminders, targets raising self-awareness, and tracks sleep. A clinician may want to review symptoms on a monthly basis. TRIAL REGISTRATION: ClinicalTrials.gov NCT03358238.
Authors: Elizabeth L Murnane; Dan Cosley; Pamara Chang; Shion Guha; Ellen Frank; Geri Gay; Mark Matthews Journal: J Am Med Inform Assoc Date: 2016-01-23 Impact factor: 4.497
Authors: K E A Saunders; A C Bilderbeck; P Panchal; L Z Atkinson; J R Geddes; G M Goodwin Journal: Eur Psychiatry Date: 2017-01-27 Impact factor: 5.361
Authors: Geoff Appelboom; Elvis Camacho; Mickey E Abraham; Samuel S Bruce; Emmanuel Lp Dumont; Brad E Zacharia; Randy D'Amico; Justin Slomian; Jean Yves Reginster; Olivier Bruyère; E Sander Connolly Journal: Arch Public Health Date: 2014-08-22
Authors: Katie M White; Charlotte Williamson; Nicol Bergou; Carolin Oetzmann; Valeria de Angel; Faith Matcham; Claire Henderson; Matthew Hotopf Journal: NPJ Digit Med Date: 2022-06-29
Authors: Sydney Hoel; Amanda Victory; Tijana Sagorac Gruichich; Zachary N Stowe; Melvin G McInnis; Amy Cochran; Emily B K Thomas Journal: Front Digit Health Date: 2022-05-12
Authors: Tijana Sagorac Gruichich; Juan Camilo David Gomez; Gabriel Zayas-Cabán; Melvin G McInnis; Amy L Cochran Journal: Bipolar Disord Date: 2021-02-26 Impact factor: 6.744
Authors: Marie-Camille Patoz; Diego Hidalgo-Mazzei; Bruno Pereira; Olivier Blanc; Ingrid de Chazeron; Andrea Murru; Norma Verdolini; Isabella Pacchiarotti; Eduard Vieta; Pierre-Michel Llorca; Ludovic Samalin Journal: Int J Bipolar Disord Date: 2021-06-03
Authors: César G Escobar-Viera; Luca C Cernuzzi; Rebekah S Miller; Hugo J Rodríguez-Marín; Eduard Vieta; Magalí González Toñánez; Lisa A Marsch; Diego Hidalgo-Mazzei Journal: Int Rev Psychiatry Date: 2021-06-09
Authors: Frederike T Fellendorf; Carlo Hamm; Nina Dalkner; Martina Platzer; Matteo C Sattler; Susanne A Bengesser; Melanie Lenger; Rene Pilz; Armin Birner; Robert Queissner; Adelina Tmava-Berisha; Michaela Ratzenhofer; Alexander Maget; Mireille van Poppel; Eva Z Reininghaus Journal: Front Psychiatry Date: 2021-03-24 Impact factor: 4.157
Authors: Emily B Kroska; Sydney Hoel; Amanda Victory; Susan A Murphy; Melvin G McInnis; Zachary N Stowe; Amy Cochran Journal: JMIR Res Protoc Date: 2020-09-23